Some US health and wellness product direct sellers are giving the US Federal Trade Commission two targets for warnings during the coronavirus pandemic: false claims about distributors' potential earnings in addition to bogus COVID-19 treatment claims.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?